Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12294610 | 1.00 | SMN1; SMN2 (0.54) | SMN1; SMN2CYP2C19POLBALDH1A1GAA | |
| SCHEMBL12294613 | 1.00 | SMN1; SMN2 (0.54) | SMN1; SMN2CYP2C19POLBALDH1A1GAA | |
| SCHEMBL2915594 | 0.88 | ALDH1A1 (0.46) | SMN1; SMN2CYP2C19POLBALDH1A1L3MBTL1 | |
| SCHEMBL2915242 | 0.88 | ALDH1A1 (0.46) | SMN1; SMN2CYP2C19POLBALDH1A1L3MBTL1 | |
| SCHEMBL1977280 | 0.88 | ALDH1A1 (0.46) | SMN1; SMN2CYP2C19POLBALDH1A1L3MBTL1 | |
| SCHEMBL12718845 | 0.84 | EPHX1 (0.59) | SMN1; SMN2CYP2C19ALDH1A1CYP2D6KDM4E | |
| SCHEMBL27607399 | 0.84 | POLB (0.59) | SMN1; SMN2CYP2C19POLBALDH1A1GAA | |
| SCHEMBL6468998 | 0.84 | SMN1; SMN2 (0.51) | SMN1; SMN2CYP2C19POLBALDH1A1GAA | |
| SCHEMBL9118493 | 0.84 | KDM4E (0.47) | SMN1; SMN2CYP2C19POLBALDH1A1L3MBTL1 | |
| SCHEMBL377609 | 0.83 | L3MBTL1 (0.61) | SMN1; SMN2CYP2C19POLBALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101260532-A | One-room type electrochemical synthesis method for alpha-phenylacetpropionic acid | UNIV EAST CHINA NORMAL (CN) | 2008-09-10 | — | — | CN | claimed |
| CN-114058237-B | Corrosion resistant coating composition | 中国涂料株式会社 | 2023-12-26 | — | — | CN | disclosed |
| CN-116981743-A | Corrosion protection composition 1 and corrosion protection coating composition | 中国涂料株式会社 | 2023-10-31 | — | — | CN | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| CN-113413456-A | Method for producing recombinant peptides and resulting peptides | OVB(爱尔兰)有限公司 | 2021-09-21 | — | — | CN | disclosed |
| CN-104662034-B | Method for producing recombinant peptides and resulting peptides | "IVIX"有限公司 | 2021-05-11 | — | — | CN | disclosed |
| US-9796705-B2 | Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases | MERCK SHARP & DOHME CORP. (US) | 2017-10-24 | — | — | US | disclosed |
| US-20170158735-A1 | METHOD FOR PRODUCING A RECOMBINANT PEPTIDE AND RESULTANT PEPTIDE | "IVIX" LTD. (RU) | 2017-06-08 | — | — | US | disclosed |
| US-20170008879-A1 | FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME CORP. (US) | 2017-01-12 | — | — | US | disclosed |
| CN-106305714-A | Fruit fly attractant concentrated solution and matched fruit fly attractant thereof | 尹正平 | 2017-01-11 | — | — | CN | disclosed |
| US-20020081675-A1 | Microbial process for preparing pravastatin | JEKKEL ANTONIA (HU) | 2002-06-27 | — | — | US | disclosed |
| US-20020022637-A1 | Tetrahydroisoquinoline analogs useful as growth hormone secretagogues | BRISTOL-MYERS SQUIBB COMPANY | 2002-02-21 | — | — | US | disclosed |
| EP-1154979-A1 | MICROBIAL PROCESS FOR PREPARING PRAVASTATIN | Institute for Drug Research Ltd. (HU) | 2001-11-21 | — | — | EP | disclosed |
| WO-2001085695-A1 | TETRAHYDROISOQUINOLINE ANALOGS USEFUL AS GROWTH HORMONE SECRETAGOGUES | BRISTOL-MYERS SQUIBB CO. (US) | 2001-11-15 | — | — | WO | disclosed |
| US-6261811-B1 | FUNGI IMMOBILIZED INTO OR ONTO LOOFAH SPONGE ; ACCELERATED PRODUCTION OF COMPOUNDS SUCH AS COMPACTIN | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2001-07-17 | — | — | US | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000046175-A1 | MICROBIAL PROCESS FOR PREPARING PRAVASTATIN | INSTITUTE FOR DRUG RESEARCH LTD. (HU) | 2000-08-10 | — | — | WO | disclosed |
| WO-2000037665-A1 | METHOD AND SYSTEM FOR THE CONTINUOUS SYNTHESIS OF NATURAL PRODUCTS USING IMMOBILIZED FUNGAL SPORES | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION (US) | 2000-06-29 | — | — | WO | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| US-4279918-A | ANTIDEPRESSANTS, STIMULANTS | BYK GULDEN LOMBERG CHEMISCHE FABRIK G.M.B.H. (DE) | 1981-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170008879-A1 | FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | ZC3HAV1, HAVCR2, ZC3HAV1L | SMN1; SMN2 957/4885CYP2C19 2096/4885POLB 801/4885 |
| US-20020022637-A1 | Tetrahydroisoquinoline analogs useful as growth hormone secretagogues | GHSR, GHRHR, MSTN | SMN1; SMN2 846/4885CYP2C19 4234/4885POLB 4093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.